SEC Filing Summary: Form 13F Information Table
Business Context and Reporting Period
Company: Bank OZK
Filing Type: Form 13F Information Table
Reporting Period: Quarter ended September 30, 2019
Context: This filing discloses the equity securities held by Bank OZK as a registered investment manager. It details holdings in various public companies, including the bank's own stock, categorized by voting authority (Sole, Shared, None) and investment discretion.
Key Financial Metrics and Holdings
Note: Form 13F filings report portfolio holdings, not the issuer's operating financials (revenue, profit, cash flow). The following metrics reflect the value and volume of securities held by Bank OZK.
- Top Holdings by Value (Sole Discretion):
- Bank OZK (Own Stock): $1,546,699,000 (1,546,699 shares)
- AT&T Inc: $120,295,000 (120,295 shares)
- Apple Inc: $31,277,000 (31,277 shares)
- Microsoft Corp: $32,112,000 (32,112 shares)
- Applied Materials Inc: $42,779,000 (42,779 shares)
- Significant Own Stock Position: Bank OZK holds a substantial position in its own common stock (CUSIP 06417N103), totaling approximately 1.85 million shares across Sole and Other discretion categories.
- Portfolio Composition: Holdings span technology (Apple, Microsoft, Cisco), healthcare (Pfizer, Merck, Medtronic), financials (JPMorgan, Bank of America), and consumer staples (PepsiCo, Coca-Cola).
Material Changes and Voting Authority
The filing distinguishes between securities held with "Sole" voting authority and those with "Other" (Shared or None) authority. Significant portions of the portfolio are held under "Other" discretion, indicating shared management or specific account structures.
- Shared/Other Discretion: Notable holdings under "Other" discretion include Bank OZK (302,633 shares), AT&T (61,318 shares), and Pfizer (19,213 shares).
- Voting Rights: For many holdings, the "Voting Authority" columns indicate split authority (e.g., Sole vs. Shared), which is standard for institutional portfolios managing multiple client accounts.
Guidance, Risks, and Contingencies
Management Commentary: This filing contains no management commentary, forward-looking guidance, or strategic outlook. It is a statutory disclosure of holdings only.
Risks and Contigencies: The filing includes a standard SEC disclaimer stating that the Commission has not reviewed the information for accuracy or completeness. No specific risk factors or contingencies regarding the bank's operations are disclosed in this document.
Key Facts for Investor Verification
- Own Stock Accumulation: Verify the total volume of Bank OZK shares held (approx. 1.85 million) to understand the bank's capital management or buyback strategy.
- Concentration Risk: Assess the concentration of the portfolio in large-cap technology and healthcare stocks relative to the bank's total assets.
- Discretion Split: Confirm the proportion of assets managed under "Sole" versus "Other" discretion to understand the scope of the bank's proprietary trading versus client advisory business.
- Missing Data: This document does not provide Bank OZK's revenue, net income, loan portfolio quality, or liquidity ratios. Investors must refer to Form 10-Q or 10-K for operational financials.